News Focus
News Focus
Followers 843
Posts 122821
Boards Moderated 10
Alias Born 09/05/2002

Re: floblu14 post# 16060

Wednesday, 11/02/2016 2:00:29 PM

Wednesday, November 02, 2016 2:00:29 PM

Post# of 20689
M254 is a new codename in MNTA’s pipeline; from today’s PR:

Momenta is also developing a hyper-sialylated IVIg (M254) as a potential high potency version of IVIg.

Unlike M281 and M230, M254 is plasma-derived, not recombinant.

In the pipeline chart in http://www.momentapharma.com/pipeline/pipeline.php , M254 is the bottommost item.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”